Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Reuss

Showing results (91-100 of 136) with videos related to

Pageof 14
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 2016
Mutant KIT as imatinib-sensitive target in metastatic sinonasal carcinomaS M Dieter, C Heining, A Agaimy, et al.
Pharmacoepidemiology and Drug Safety|November 25, 2024
Determining Line of Therapy from Real-World Data in Non-Small Cell Lung CancerConnor B Grady, Wei-Ting Hwang, Joshua E Reuss, et al.
Brain Pathology (Zurich, Switzerland)|November 18, 2014
Melanotic tumors of the nervous system are characterized by distinct mutational, chromosomal and epigenomic profilesChristian Koelsche, Volker Hovestadt, David T W Jones, et al.
Acta Neuropathologica|June 20, 2015
Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entitiesDavid E Reuss, Annekathrin Kratz, Felix Sahm, et al.
Neuropathology and Applied Neurobiology|December 18, 2020
Accurate calling of KIAA1549-BRAF fusions from DNA of human brain tumours using methylation array-based copy number and gene panel sequencing dataDamian Stichel, Daniel Schrimpf, Philipp Sievers, et al.
Journal for Immunotherapy of Cancer|June 10, 2022
Peripheral blood immune cell dynamics reflect antitumor immune responses and predict clinical response to immunotherapyMichael Hwang, Jenna Vanliere Canzoniero, Samuel Rosner, et al.
Nature Medicine|September 8, 2025
Perioperative nivolumab or nivolumab plus ipilimumab in resectable diffuse pleural mesothelioma: a phase 2 trial and ctDNA analysesJoshua E Reuss, Paul K Lee, Reza J Mehran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2024
Divergent Clinical and Immunologic Outcomes Based on STK11 Co-mutation Status in Resectable KRAS-Mutant Lung Cancers Following Neoadjuvant Immune Checkpoint BlockadeSamuel Rosner, Sydney Connor, Khaled Sanber, et al.
NPJ Precision Oncology|March 25, 2023
Pediatric-type high-grade neuroepithelial tumors with CIC gene fusion share a common DNA methylation signaturePhilipp Sievers, Martin Sill, Daniel Schrimpf, et al.
Acta Neuropathologica|February 10, 2016
Methylation-based classification of benign and malignant peripheral nerve sheath tumorsManuel Röhrich, Christian Koelsche, Daniel Schrimpf, et al.
Pageof 14

Showing results (91-100 of 136) with videos related to

Sort By:
Pageof 14
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 2016
Mutant KIT as imatinib-sensitive target in metastatic sinonasal carcinomaS M Dieter, C Heining, A Agaimy, et al.
Pharmacoepidemiology and Drug Safety|November 25, 2024
Determining Line of Therapy from Real-World Data in Non-Small Cell Lung CancerConnor B Grady, Wei-Ting Hwang, Joshua E Reuss, et al.
Brain Pathology (Zurich, Switzerland)|November 18, 2014
Melanotic tumors of the nervous system are characterized by distinct mutational, chromosomal and epigenomic profilesChristian Koelsche, Volker Hovestadt, David T W Jones, et al.
Acta Neuropathologica|June 20, 2015
Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entitiesDavid E Reuss, Annekathrin Kratz, Felix Sahm, et al.
Neuropathology and Applied Neurobiology|December 18, 2020
Accurate calling of KIAA1549-BRAF fusions from DNA of human brain tumours using methylation array-based copy number and gene panel sequencing dataDamian Stichel, Daniel Schrimpf, Philipp Sievers, et al.
Journal for Immunotherapy of Cancer|June 10, 2022
Peripheral blood immune cell dynamics reflect antitumor immune responses and predict clinical response to immunotherapyMichael Hwang, Jenna Vanliere Canzoniero, Samuel Rosner, et al.
Nature Medicine|September 8, 2025
Perioperative nivolumab or nivolumab plus ipilimumab in resectable diffuse pleural mesothelioma: a phase 2 trial and ctDNA analysesJoshua E Reuss, Paul K Lee, Reza J Mehran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2024
Divergent Clinical and Immunologic Outcomes Based on STK11 Co-mutation Status in Resectable KRAS-Mutant Lung Cancers Following Neoadjuvant Immune Checkpoint BlockadeSamuel Rosner, Sydney Connor, Khaled Sanber, et al.
NPJ Precision Oncology|March 25, 2023
Pediatric-type high-grade neuroepithelial tumors with CIC gene fusion share a common DNA methylation signaturePhilipp Sievers, Martin Sill, Daniel Schrimpf, et al.
Acta Neuropathologica|February 10, 2016
Methylation-based classification of benign and malignant peripheral nerve sheath tumorsManuel Röhrich, Christian Koelsche, Daniel Schrimpf, et al.
Pageof 14